Héma-Québec's Montréal facilities pass annual inspection

Montréal, January 30, 2007 – Héma-Québec has passed annual inspection at its Montréal facilities. Consequently, inspectors of Health Canada maintained Héma-Québec's operating licence. The yearly procedural audit took place between November 20 and December 1, 2006.

Throughout the audit of the Montréal facilities, the Health Canada inspectors noted that the safety of blood components is a priority for all Héma-Québec personnel. Health Canada inspects each facility of Héma-Québec once a year to ensure compliance with safety measures and with the requirements stipulated in its operating licence.

The inspectors made minor observations without any major direct effect on product safety. Corrective measures have already been, or soon will be, implemented. These observations deal primarily with improving compliance with Good Manufacturing Practices (GMP).

Created in 1998, Héma-Québec's mission is to efficiently provide adequate quantities of safe, optimal blood components, substitutes, human tissues and cord blood to meet the needs of all Quebecers; provide and develop expertise along with specialized and innovative services and products in the fields of transfusion medicine and human tissue transplantation.

Héma-Québec is 1,300 employees, some 3,000 days of blood drives and more than 300,000 blood donors each year, 16,000 volunteer partners and 400,000 blood products delivered each year to Québec hospitals to meet patients' needs.


  Observations and Responses